IL1RL1 and Lymphatic Metastasis: ST2 immunoreactivity in the stroma is diminished both in patients with lymphatic metastasis [Figure 4A, Mean positivity per area ± SD (Pos/area AU, arbitrary units): 0.232 ± 0.06 vs. 0.377 ± 0.14 without LN metastasis, respectively.